Renaissance Technologies
ARMP icon

Renaissance Technologies’s Armata Pharmaceuticals ARMP Stock Holding History

Renaissance Technologies’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$394K Sell
38,496
-30,000
-44% -$252K ﹤0.01% 2698
2025
Q4 		$430K Buy
68,496
+27,200
+66% +$149K ﹤0.01% 2633
2025
Q3 		$123K Buy
41,296
+2,400
+6% +$6.21K ﹤0.01% 3230
2025
Q2 		$73.9K Buy
38,896
+300
+0.8% +$486 ﹤0.01% 3342
2025
Q1 		$56.4K Sell
38,596
-1,695
-4% -$3.38K ﹤0.01% 3276
2024
Q4 		$74.5K Sell
40,291
-6,205
-13% -$13.9K ﹤0.01% 3327
2024
Q3 		$110K Sell
46,496
-1,700
-4% -$4.35K ﹤0.01% 3245
2024
Q2 		$133K Sell
48,196
-3,200
-6% -$9.13K ﹤0.01% 3131
2024
Q1 		$215K Sell
51,396
-2,200
-4% -$7.96K ﹤0.01% 3206
2023
Q4 		$174K Sell
53,596
-3,900
-7% -$9.21K ﹤0.01% 3177
2023
Q3 		$172K Sell
57,496
-4,900
-8% -$13.1K ﹤0.01% 3128
2023
Q2 		$71K Sell
62,396
-800
-1% -$1.16K ﹤0.01% 3547
2023
Q1 		$106K Sell
63,196
-10,500
-14% -$24.4K ﹤0.01% 3475
2022
Q4 		$91K Buy
73,696
+3,900
+6% +$10.2K ﹤0.01% 3650
2022
Q3 		$295K Sell
69,796
-10,200
-13% -$41.1K ﹤0.01% 3219
2022
Q2 		$311K Sell
79,996
-1,700
-2% -$7.38K ﹤0.01% 3432
2022
Q1 		$399K Sell
81,696
-3,100
-4% -$15.9K ﹤0.01% 3324
2021
Q4 		$465K Sell
84,796
-21,296
-20% -$89K ﹤0.01% 3114
2021
Q3 		$384K Sell
106,092
-10,604
-9% -$40.4K ﹤0.01% 2994
2021
Q2 		$463K Sell
116,696
-7,120
-6% -$30K ﹤0.01% 2991
2021
Q1 		$592K Buy
123,816
+24,820
+25% +$122K ﹤0.01% 2843
2020
Q4 		$295K Buy
98,996
+5,298
+6% +$16.8K ﹤0.01% 3040
2020
Q3 		$299K Buy
93,698
+8,821
+10% +$31K ﹤0.01% 2996
2020
Q2 		$333K Buy
84,877
+18,150
+27% +$62.9K ﹤0.01% 3000
2020
Q1 		$207K Sell
66,727
-7,427
-10% -$25.6K ﹤0.01% 3092
2019
Q4 		$241K Sell
74,154
-1,500
-2% -$6.04K ﹤0.01% 3143
2019
Q3 		$280K Buy
75,654
+800
+1% +$3.15K ﹤0.01% 3057
2019
Q2 		$300K Buy
74,854
+29,594
+65% +$113K ﹤0.01% 3172
2019
Q1 		$191K Buy
45,260
+14,370
+47% +$54.6K ﹤0.01% 3219
2018
Q4 		$89K Buy
30,890
+15,614
+102% +$76.1K ﹤0.01% 3244
2018
Q3 		$216K Buy
15,276
+3,636
+31% +$53.1K ﹤0.01% 3127
2018
Q2 		$184K Buy
11,640
+2,686
+30% +$43.7K ﹤0.01% 3085
2018
Q1 		$137K Sell
8,954
-929
-9% -$16.5K ﹤0.01% 3229
2017
Q4 		$140K Buy
9,883
+1,843
+23% +$27.2K ﹤0.01% 3188
2017
Q3 		$102K Sell
8,040
-1,179
-13% -$15.1K ﹤0.01% 3079
2017
Q2 		$101K Buy
+9,219
New +$224K ﹤0.01% 3083
2017
Q1 		– Sell
-500
Closed -$31K – 3213
2016
Q4 		$31K Buy
500
+379
+313% +$47.1K ﹤0.01% 3191
2016
Q3 		$26K Buy
121
+6
+5% +$1.38K ﹤0.01% 3281
2016
Q2 		$25K Buy
+115
New +$39.7K ﹤0.01% 3274

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.06B AUM 11.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies's ARMP Position: Q1 2026 in Review

Renaissance Technologies reduced its Armata Pharmaceuticals (ARMP) stake by 44% in Q1 2026, selling an estimated $252K and leaving 38,496 shares worth $394K. The position accounts for ﹤0.01% of the portfolio, ranked #2698.

Renaissance Technologies first reported a position in ARMP in Q2 2016 and has held it in 39 quarters since. The position peaked at $592K in Q1 2021. 45 funds tracked by Wall St. Rank hold ARMP as of Q1 2026.

  • Renaissance Technologies held 38,496 shares of Armata Pharmaceuticals worth $394K as of Q1 2026.
  • Renaissance Technologies sold 30,000 Armata Pharmaceuticals shares in Q1 2026, an estimated $252K.
  • Armata Pharmaceuticals made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2698 holding.
  • Renaissance Technologies first reported a position in Armata Pharmaceuticals in Q2 2016 and has held it in 39 quarters since.
  • Renaissance Technologies's Armata Pharmaceuticals position peaked at $592K in Q1 2021.
  • 45 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.